These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 19434638)

  • 1. Synthesis and in vitro activity of heterocyclic inhibitors of CYP2A6 and CYP2A13, two cytochrome P450 enzymes present in the respiratory tract.
    Chougnet A; Woggon WD; Locher E; Schilling B
    Chembiochem; 2009 Jun; 10(9):1562-7. PubMed ID: 19434638
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic inhibitors of cytochrome P-450 2A6: inhibitory activity, difference spectra, mechanism of inhibition, and protein cocrystallization.
    Yano JK; Denton TT; Cerny MA; Zhang X; Johnson EF; Cashman JR
    J Med Chem; 2006 Nov; 49(24):6987-7001. PubMed ID: 17125252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative structure-activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
    Rahnasto M; Raunio H; Poso A; Wittekindt C; Juvonen RO
    J Med Chem; 2005 Jan; 48(2):440-9. PubMed ID: 15658857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of inhibitors of the nicotine metabolising CYP2A6 enzyme--an in silico approach.
    Rahnasto M; Wittekindt C; Juvonen RO; Turpeinen M; Petsalo A; Pelkonen O; Poso A; Stahl G; Höltje HD; Raunio H
    Pharmacogenomics J; 2008 Oct; 8(5):328-38. PubMed ID: 17923852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inhibition selectivity for human cytochrome P450 2A enzymes.
    Stephens ES; Walsh AA; Scott EE
    Drug Metab Dispos; 2012 Sep; 40(9):1797-802. PubMed ID: 22696418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
    Su T; Bao Z; Zhang QY; Smith TJ; Hong JY; Ding X
    Cancer Res; 2000 Sep; 60(18):5074-9. PubMed ID: 11016631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of human cytochromes P450 2A6 and 2A13 by flavonoids, acetylenic thiophenes and sesquiterpene lactones from Pluchea indica and Vernonia cinerea.
    Boonruang S; Prakobsri K; Pouyfung P; Srisook E; Prasopthum A; Rongnoparut P; Sarapusit S
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1136-1142. PubMed ID: 28856944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition and inactivation of cytochrome P450 2A6 and cytochrome P450 2A13 by menthofuran, β-nicotyrine and menthol.
    Kramlinger VM; von Weymarn LB; Murphy SE
    Chem Biol Interact; 2012 May; 197(2-3):87-92. PubMed ID: 22486895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic models related to methoxalen and menthofuran-cytochrome P450 (CYP) 2A6 interactions. benzofuran and coumarin derivatives as potent and selective inhibitors of CYP2A6.
    Yamaguchi Y; Akimoto I; Motegi K; Yoshimura T; Wada K; Nishizono N; Oda K
    Chem Pharm Bull (Tokyo); 2013; 61(10):997-1001. PubMed ID: 23902929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism.
    von Weymarn LB; Brown KM; Murphy SE
    J Pharmacol Exp Ther; 2006 Jan; 316(1):295-303. PubMed ID: 16188955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationship and
    Boonruang S; Prakobsri K; Pouyfung P; Prasopthum A; Rongnoparut P; Sarapusit S
    Xenobiotica; 2020 Jun; 50(6):630-639. PubMed ID: 31578905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential distribution of CYP2A6 and CYP2A13 in the human respiratory tract.
    Chiang HC; Wang CK; Tsou TC
    Respiration; 2012; 84(4):319-26. PubMed ID: 22890016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of novel CYP2A6 inhibitors by virtual screening.
    Rahnasto MK; Raunio HA; Wittekindt C; Salminen KA; Leppänen J; Juvonen RO; Poso A; Lahtela-Kakkonen MK
    Bioorg Med Chem; 2011 Dec; 19(23):7186-93. PubMed ID: 22019468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Key residues controlling binding of diverse ligands to human cytochrome P450 2A enzymes.
    DeVore NM; Smith BD; Wang JL; Lushington GH; Scott EE
    Drug Metab Dispos; 2009 Jun; 37(6):1319-27. PubMed ID: 19251817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-substituted, 6-substituted, and unsubstituted 3-heteroaromatic pyridine analogues of nicotine as selective inhibitors of cytochrome P-450 2A6.
    Denton TT; Zhang X; Cashman JR
    J Med Chem; 2005 Jan; 48(1):224-39. PubMed ID: 15634016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CYP2A6- and CYP2A13-catalyzed metabolism of the nicotine Δ5'(1')iminium ion.
    von Weymarn LB; Retzlaff C; Murphy SE
    J Pharmacol Exp Ther; 2012 Nov; 343(2):307-15. PubMed ID: 22869927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conceptual DFT properties-based 3D QSAR: analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
    Van Damme S; Bultinck P
    J Comput Chem; 2009 Sep; 30(12):1749-57. PubMed ID: 19090569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism-based inactivation of cytochrome P450 2A6 and 2A13 by Rhinacanthus nasutus constituents.
    Pouyfung P; Prasopthum A; Sarapusit S; Srisook E; Rongnoparut P
    Drug Metab Pharmacokinet; 2014; 29(1):75-82. PubMed ID: 23903410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key residues controlling phenacetin metabolism by human cytochrome P450 2A enzymes.
    DeVore NM; Smith BD; Urban MJ; Scott EE
    Drug Metab Dispos; 2008 Dec; 36(12):2582-90. PubMed ID: 18779312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a range of phenyl alkyl imidazole-based compounds as potent inhibitors of the enzyme complex 17alpha-hydroxylase/17,20-lyase (P450(17alpha)).
    Owen CP; Shahid I; Olusanjo MS; Patel CH; Dhanani S; Ahmed S
    J Steroid Biochem Mol Biol; 2008 Jul; 111(1-2):117-27. PubMed ID: 18620055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.